Skip to content

Pulmonx Corp

LUNG· NasdaqCore metricsCIK 1127537

Surgical & medical instruments & apparatus142 peers

Last sale
Nov 12, 2026 · +1.18%
Market cap
$130.87M
43.55M shares
Filings
451
$22.84M
Q3 2026+8.0% FY25 yoy
-$8.39M
Q3 2026N/M FY25 yoy
-$7.49M
Q3 2026N/M FY25 yoy
-$18.51M
Q3 2026derivedN/M FY25 yoy
-$0.19
Q3 2026N/M FY25 yoy
$52.69M
Q3 2026−1.6% FY25 yoy
$130.87M
—
1.5×
3.8×
-19.57%
—

Twelve months to Sep 30, 2026 · derived

Price

$3.01+43.78%+$0.92past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$90.50MFY 2025
$90.50M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$90,497,000reported
FY 20242024-12-31$83,789,000reported
FY 20232023-12-31$68,675,000reported
FY 20222022-12-31$53,662,000reported
FY 20212021-12-31$48,416,000reported
FY 20202020-12-31$32,733,000reported
FY 20192019-12-31$32,595,000reported
FY 20182018-12-31$20,004,000reported

Capital returns

Dividends and buybacks · FY2018 to FY2023
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$0.00$0.00—38.54M sh+2.4%—
FY2022—$27.00K$27.00K—37.65M sh+1.7%—
FY2021—$26.00K$26.00K—37.02M sh+3.7%—
FY2020—$21.00K$21.00K—35.69M sh+1,599.4%—
FY2019—$12.00K$12.00K—2.10M sh——

Segments

Geography
Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $563.00KEurope, Middle-East and Africa (“EMEA”) · FY2018 · $16.18MAsia Pacific · FY2018 · $3.12MOther International · FY2018 · $151.00KFY2019United States · FY2019 · $10.70MEurope, Middle-East and Africa (“EMEA”) · FY2019 · $18.36MAsia Pacific · FY2019 · $3.23MOther International · FY2019 · $300.00KFY2020United States · FY2020 · $16.19MEurope, Middle-East and Africa (“EMEA”) · FY2020 · $13.81MAsia Pacific · FY2020 · $2.69MOther International · FY2020 · $49.00KFY2021United States · FY2021 · $24.99MEurope, Middle-East and Africa (“EMEA”) · FY2021 · $19.88MAsia Pacific · FY2021 · $3.41MOther International · FY2021 · $128.00KFY2022United States · FY2022 · $32.49MEurope, Middle-East and Africa (“EMEA”) · FY2022 · $18.15MAsia Pacific · FY2022 · $2.87MOther International · FY2022 · $155.00KFY2023United States · FY2023 · $45.92MEurope, Middle-East and Africa (“EMEA”) · FY2023 · $19.34MAsia Pacific · FY2023 · $3.02MOther International · FY2023 · $399.00KFY2024United States · FY2024 · $56.47MEurope, Middle-East and Africa (“EMEA”) · FY2024 · $22.33MAsia Pacific · FY2024 · $4.44MOther International · FY2024 · $556.00KFY2025United States · FY2025 · $57.02MEurope, Middle-East and Africa (“EMEA”) · FY2025 · $26.99MAsia Pacific · FY2025 · $6.23MOther International · FY2025 · $260.00K
LineFY2025ShareChange
United States$57.02M63%+1.0%
Europe, Middle-East and Africa (“EMEA”)$26.99M30%+20.9%
Asia Pacific$6.23M6.9%+40.3%
Other International$260.00K0.3%−53.2%
Total$90.50M

From the 10-K filed Mar 10, 2026LUNG

Surgical & medical instruments & apparatus

Pulmonx Corp is the 52nd largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Pulmonx Corp · CIK 1127537 · Engraved from SEC EDGAR